Clinical Trials Logo

Filter by:
NCT ID: NCT03098927 Withdrawn - Clinical trials for Spinal Cord Injuries

Mirror Neuron Network Based Motor Imagery Training to Improve Brain Computer Interface Performance in Spinal Cord Injury Patients

BCI
Start date: September 1, 2014
Phase: N/A
Study type: Interventional

The overall vision of this proposal is to demonstrate that a virtual reality based motor imagery training program will improve brain computer interface (BCI) performance and motor function in quadriplegic subjects. The ultimate goal is to increase the independence of subjects with spinal cord injury by training to safely control BCI assistive devices and to enhance motor recovery.

NCT ID: NCT03097796 Withdrawn - Clinical trials for Hematologic Diseases

A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients

Start date: December 2024
Phase: Phase 1
Study type: Interventional

Subjects with hematologic malignancies or recipients of a first allogenic or autologus hematopoietic stem cell transplant, without any evidence or respiratory infection, will receive 4 doses of PUL-042 Inhalation Solution over a 2 week period. Subjects will be evaluated for tolerability of the drug. If tolerated, dose escalation may occur with up to 4 dose levels tested

NCT ID: NCT03096899 Withdrawn - Clinical trials for Metastatic Colorectal Carcinoma

A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma

Start date: January 2016
Phase:
Study type: Observational

The primary objective of this study is to estimate overall survival in patients only receiving best supportive care (BSC) for treatment-resistant, metastatic colorectal carcinoma. The primary efficacy outcome is overall survival, defined as the time from the date of the radiographic scan demonstrating disease progression post available treatments (time of origin, T0) to death from any cause.

NCT ID: NCT03095222 Withdrawn - Pain Clinical Trials

Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to identify the optimal dosing strategy for low-dose ketamine infusions in adult acute burn injury patients when used with usual pain medications.

NCT ID: NCT03094559 Withdrawn - Clinical trials for Critical Limb Ischemia

Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)

Start date: March 7, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the utility of the FlowMet™ device in the assessment of perfusion in subjects suspected of or being treated for critical limb ischemia, in comparison to other gold standard technologies, such as ankle brachial pulse index (ABI), skin perfusion pressure (SPP), toe brachial pulse index (TBI), transcutaneous oxygen tension (TcP02), and angiography currently in use in the clinic.

NCT ID: NCT03094468 Withdrawn - Clinical trials for Onychomycosis of Toenail

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Start date: May 2017
Phase: Phase 3
Study type: Interventional

The aim of this phase III study is to establish the efficacy and safety of P-3058 (terbinafine 10% nail solution) topically administered once weekly in patients with onychomycosis in comparison to the Vehicle in a double-blind fashion. The overall treatment period will be of 48 weeks.

NCT ID: NCT03094442 Withdrawn - Quality of Life Clinical Trials

Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?

Start date: December 2016
Phase: N/A
Study type: Interventional

The primary aim is to evaluate whether standard administration of Dexamethasone at the time of general anesthesia induction at the time of minimally invasive sacrocolpopexy (MISC) would result in improved quality of recovery (QoR).

NCT ID: NCT03093740 Withdrawn - Hepatitis C Clinical Trials

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Start date: October 1, 2018
Phase: Phase 4
Study type: Interventional

Open label single center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.

NCT ID: NCT03093090 Withdrawn - Clinical trials for Medication Absorption

Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide

Start date: December 31, 2018
Phase: Phase 1
Study type: Interventional

Poorly absorbed medications such as furosemide are common and recent experiments suggest that improvement in absorption can occur if these types of medications are consumed with liquids such as milk. The purpose of this study is to evaluate the absorption of furosemide in normal adults when taken with bottled water, milk (Parmalat™ Whole Milk), baby formula (Similac Pro-Advance™), or Ensure Plus™. These results will be used to make models that predict how these liquids will affect drug absorption in children, potentially providing ways to improve medication absorption in children.

NCT ID: NCT03093077 Withdrawn - Clinical trials for Osteoarthritis, Knee

Kinematics After Total Knee Arthroplasty

Start date: November 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate and compare implant kinematics of conventional mechanically aligned and anatomically aligned total knee arthroplasties (TKA) at 1 year post-operatively.